Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Aashish Manglik
Affiliation
Department of Pharmaceutical Chemistry, University of California San Francisco
ORCID
Career Start Year
2008
Papers
62
H Index
40
Expertise
CM4AI Collaborator
Trey Ideker (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36922591
Structural basis of odorant recognition by a human odorant receptor.
Nature
2023
38014344
Engineered odorant receptors illuminate structural principles of odor discrimination.
bioRxiv
2023
37828150
Rare antibody phage isolation and discrimination (RAPID) biopanning enables identification of high-affinity antibodies against challenging targets.
Commun Biol
2023
37292845
GPR161 structure uncovers the redundant role of sterol-regulated ciliary cAMP signaling in the Hedgehog pathway.
bioRxiv
2023
34711980
Selective G protein signaling driven by substance P-neurokinin receptor dynamics.
Nat Chem Biol
2022
36250629
Discrete GPCR-triggered endocytic modes enable β-arrestins to flexibly regulate cell signaling.
Elife
2022
35940205
Autoantibody mimicry of hormone action at the thyrotropin receptor.
Nature
2022
35902590
Fusion protein strategies for cryo-EM study of G protein-coupled receptors.
Nat Commun
2022
34562250
Biochemical Assays to Directly Assess Smoothened Activation by a Conformationally Sensitive Nanobody.
Methods Mol Biol
2022
33974910
Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia.
Cell
2021
33893299
Protein design and variant prediction using autoregressive generative models.
Nat Commun
2021
33727310
Surface Proteomics Reveals CD72 as a Target for <i>In Vitro</i>-Evolved Nanobody-Based CAR-T Cells in <i>KMT2A/MLL1</i>-Rearranged B-ALL.
Cancer Discov
2021
34013269
CryoEM and AI reveal a structure of SARS-CoV-2 Nsp2, a multifunctional protein involved in key host processes.
bioRxiv
2021
34031651
CryoEM and AI reveal a structure of SARS-CoV-2 Nsp2, a multifunctional protein involved in key host processes.
Res Sq
2021
32511497
Test performance evaluation of SARS-CoV-2 serological assays.
medRxiv
2020
34109255
Universal Polymerase Chain Reaction and Antibody Testing Demonstrate Little to No Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in a Rural Community.
Open Forum Infect Dis
2020
32096468
Agonist-selective recruitment of engineered protein probes and of GRK2 by opioid receptors in living cells.
Elife
2020
31653480
Molecular Basis of Opioid Action: From Structures to New Leads.
Biol Psychiatry
2020
33060197
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.
Science
2020
33139559
Hedgehog pathway activation through nanobody-mediated conformational blockade of the Patched sterol conduit.
Proc Natl Acad Sci U S A
2020
33154106
An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike.
Science
2020
32855547
Evaluation of SARS-CoV-2 serology assays reveals a range of test performance.
Nat Biotechnol
2020
32817938
An ultra-potent synthetic nanobody neutralizes SARS-CoV-2 by locking Spike into an inactive conformation.
bioRxiv
2020
32699850
Bivalent binding of a fully human IgG to the SARS-CoV-2 spike proteins reveals mechanisms of potent neutralization.
bioRxiv
2020
32814342
Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms.
Nature
2020
32724208
Author Correction: Structural insights into μ-opioid receptor activation.
Nature
2020
32412788
β-Arrestin-Biased Angiotensin II Receptor Agonists for COVID-19.
Circulation
2020
31263273
Smoothened stimulation by membrane sterols drives Hedgehog pathway activity.
Nature
2019
29434346
Yeast surface display platform for rapid discovery of conformationally selective nanobodies.
Nat Struct Mol Biol
2018
30213947
Development of an antibody fragment that stabilizes GPCR/G-protein complexes.
Nat Commun
2018
29932421
Measuring ligand efficacy at the mu-opioid receptor using a conformational biosensor.
Elife
2018
29899455
Structure of the µ-opioid receptor-G<sub>i</sub> protein complex.
Nature
2018
29754753
A Genetically Encoded Biosensor Reveals Location Bias of Opioid Drug Action.
Neuron
2018
29581292
Sortase ligation enables homogeneous GPCR phosphorylation to reveal diversity in β-arrestin coupling.
Proc Natl Acad Sci U S A
2018
27959623
Nanobodies to Study G Protein-Coupled Receptor Structure and Function.
Annu Rev Pharmacol Toxicol
2017
28967738
Structural Basis for G Protein-Coupled Receptor Activation.
Biochemistry
2017
26894529
High-density grids for efficient data collection from multiple crystals.
Acta Crystallogr D Struct Biol
2016
27362234
Allosteric coupling from G protein to the agonist-binding pocket in GPCRs.
Nature
2016
27533032
Structure-based discovery of opioid analgesics with reduced side effects.
Nature
2016
27409812
Allosteric nanobodies reveal the dynamic range and diverse mechanisms of G-protein-coupled receptor activation.
Nature
2016
27042935
Crystal structure of the human Ͽ1 receptor.
Nature
2016
25770216
G Protein-coupled Receptor Kinases of the GRK4 Protein Subfamily Phosphorylate Inactive G Protein-coupled Receptors (GPCRs).
J Biol Chem
2015
26245379
Structural insights into µ-opioid receptor activation.
Nature
2015
26245377
Propagation of conformational changes during μ-opioid receptor activation.
Nature
2015
26604307
Engineering high-affinity PD-1 variants for optimized immunotherapy and immuno-PET imaging.
Proc Natl Acad Sci U S A
2015
26089515
SIGNAL TRANSDUCTION. Structural basis for nucleotide exchange in heterotrimeric G proteins.
Science
2015
25981665
Structural Insights into the Dynamic Process of β2-Adrenergic Receptor Signaling.
Cell
2015
25813845
A comparison of chemical shift sensitivity of trifluoromethyl tags: optimizing resolution in ¹â¹F NMR studies of proteins.
J Biomol NMR
2015
24534489
The role of protein dynamics in GPCR function: insights from the β2AR and rhodopsin.
Curr Opin Cell Biol
2014
25362050
Goniometer-based femtosecond crystallography with X-ray free electron lasers.
Proc Natl Acad Sci U S A
2014
1 - 50 of 62
Column Actions
Search
Recommended Authors
Michael J Robertson
Stanford University School of Medicine
Career Start Year
2015
Number of shared co-authors
8
Xianjun Zhang
iHuman Institute, ShanghaiTech University
Career Start Year
2015
Number of shared co-authors
1
Timothy S Strutzenberg
Salk Institute for Biological Studies
Career Start Year
2014
Number of shared co-authors
2
Kate L White
Lawrence Berkeley National Laboratory
Career Start Year
2012
Number of shared co-authors
4
Kuglae Kim
University of North Carolina School of Medicine
Career Start Year
2011
Number of shared co-authors
8
Alpay B Seven
Stanford University School of Medicine
Career Start Year
2011
Number of shared co-authors
8
Joel Karpiak
Department of Pharmaceutical Sciences, University of California San Francisco
Career Start Year
2009
Number of shared co-authors
5
Luis Esquivies
Stanford University
Career Start Year
2007
Number of shared co-authors
1
Suwen Zhao
ShanghaiTech University, China iHuman Institute
Career Start Year
2006
Number of shared co-authors
6
Qi Chen
Lilly Research Laboratories
Career Start Year
2006
Number of shared co-authors
1
Jens Carlsson
Uppsala University
Career Start Year
2004
Number of shared co-authors
3
Brian E Krumm
University of North Carolina School of Medicine
Career Start Year
2003
Number of shared co-authors
8
Anita M Preininger
IBM Corporation
Career Start Year
2002
Number of shared co-authors
0
Jonathan F Fay
University of North Carolina School of Medicine
Career Start Year
2002
Number of shared co-authors
8
Joseph D Ho
University of California san francisco
Career Start Year
2000
Number of shared co-authors
2
Christopher J Langmead
Monash University
Career Start Year
2000
Number of shared co-authors
0
Jonathan Solberg
Institute for Therapeutics Discovery and Development, University of Minnesota
Career Start Year
2000
Number of shared co-authors
1
Judith Klein-Seetharaman
School of Molecular Sciences & College of Health Solutions, Arizona State University
Career Start Year
1999
Number of shared co-authors
5
Peter Kolb
Institut fur Pharmazeutische Chemie, Philipps-Universitat Marburg
Career Start Year
1996
Number of shared co-authors
3
Witek Kwiatkowski
Swiss Federal Institute of Technology
Career Start Year
1996
Number of shared co-authors
3
Daniel L Minor
Cardiovascular Research Institute, University of California san francisco
Career Start Year
1994
Number of shared co-authors
11
Gye Won Han
Bridge Institute, University of Southern California
Career Start Year
1991
Number of shared co-authors
4
Pei Tang
Sichuan University
Career Start Year
1989
Number of shared co-authors
4
Raymond C Stevens
iHuman Institute, ShanghaiTech University
Career Start Year
1988
Number of shared co-authors
6
Patrick R Griffin
The Scripps Research Institute
Career Start Year
1987
Number of shared co-authors
7
Senyon Choe
Joint Center for Biosciences
Career Start Year
1986
Number of shared co-authors
3
Michel Bouvier
Institute for Research in Immunology and Cancer, Universite de Montreal
Career Start Year
1981
Number of shared co-authors
8
Ruben Abagyan
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California
Career Start Year
1981
Number of shared co-authors
2
Harel Weinstein
Institute for Computational Biomedicine
Career Start Year
1973
Number of shared co-authors
7
Jens Meiler
Vanderbilt University
Career Start Year
1954
Number of shared co-authors
3
row(s) 1 - 30 of 30
Collaborators
Andrew C Kruse
Blavatnik Institute, Harvard Medical School
Co-authored papers
17
Yifan Cheng
Quantitative Bioscience Institute, University of California san francisco
Co-authored papers
10
Christian B Billesb??lle
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers
9
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers
7
Kaihua Zhang
Henan Normal University
Co-authored papers
7
Ishan Deshpande
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers
6
Caleigh M Azumaya
Fred Hutchinson Cancer Center
Co-authored papers
6
Gregory E Merz
University of California san francisco
Co-authored papers
5
Kaitlin Schaefer
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers
5
Alexandrea N Rizo
University of California san francisco
Co-authored papers
5
Danielle L Swaney
J. David Gladstone Institutes
Co-authored papers
5
David Bulkley
University of California, San Francisco (UCSF) School of Medicine
Co-authored papers
5
Sergei Pourmal
University of California san francisco
Co-authored papers
5
Daniel Asarnow
University of California San Francisco
Co-authored papers
5
Un Seng Chio
University of California san francisco
Co-authored papers
5
Raphael Trenker
Cardiovascular Research Institute, University of California San Francisco
Co-authored papers
5
Huong T Kratochvil
Department of Pharmaceutical Chemistry, University of California-San Francisco
Co-authored papers
5
Meghna Gupta
University of California san francisco
Co-authored papers
5
Amber M Smith
University of California san francisco
Co-authored papers
5
Axel F Brilot
University of California san francisco
Co-authored papers
5
Cristina Puchades
University of California San Francisco (UCSF) School of Medicine
Co-authored papers
5
Henry C Nguyen
Shanghai Clinical Research and Trial Center
Co-authored papers
5
Aaron M Ring
Yale University School of Medicine
Co-authored papers
4
Yanxin Liu
University of California san francisco
Co-authored papers
4
James S Fraser
University of California san francisco
Co-authored papers
4
Robert J Lefkowitz
Co-authored papers
4
Carl-Mikael Suomivuori
Stanford University School of Medicine
Co-authored papers
3
Nadia Herrera
University of California san francisco
Co-authored papers
3
Eric Tse
School of Clinical Medicine, University of Hong Kong
Co-authored papers
3
Lily Y-L Lee
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers
3
1 - 30